United States · FDA National Drug Code directory
ATORVASTATIN CALCIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0615-8009_77d8e3d2-c909-4c76-9572-f838179cd722
- Product NDC
- 0615-8009
- Form
- TABLET, FILM COATED
- Composition / generic term
- ATORVASTATIN CALCIUM
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120529
- Source listing expiry
- 20261231
Source-listed ingredients
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8009-05) · 0615-8009-05
- 7 TABLET, FILM COATED in 1 BLISTER PACK (0615-8009-07) · 0615-8009-07
- 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8009-39) · 0615-8009-39
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →